Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Biological & Pharmaceutical Bulletin
|
January 5, 2002
Spray-dried powders as nasal absorption enhancers of cyanocobalamin
A García-Arieta, S Torrado-Santiago, L Goya, et al.
The AAPS Journal
|
March 20, 2015
On the Incorrect Statistical Calculations of the Kinetica Software Package in Imbalanced Designs
S Morales-Alcelay, J M de la Torre de Alvarado, A García-Arieta
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
April 23, 2018
Defining level A IVIVC dissolution specifications based on individual in vitro dissolution profiles of a controlled release formulation
I González-García, A García-Arieta, M Merino-Sanjuan, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
March 7, 2000
Quantitative determination of dimethicone in commercial tablets and capsules by Fourier transform infrared spectroscopy and antifoaming activity test
G Torrado, A García-Arieta, F de los Ríos, et al.
Clinical Pharmacology and Therapeutics
|
July 3, 2014
Adjusted indirect treatment comparison of the bioavailability of WHO-prequalified first-line generic antituberculosis medicines
L Gwaza, J Gordon, J Welink, et al.
Die Pharmazie
|
February 15, 2018
IVIVC approach based on carbamazepine bioequivalence studies combination
I González-García, V Mangas-Sanjuan, M Merino-Sanjuán, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Biological & Pharmaceutical Bulletin
|
January 5, 2002
Spray-dried powders as nasal absorption enhancers of cyanocobalamin
A García-Arieta, S Torrado-Santiago, L Goya, et al.
The AAPS Journal
|
March 20, 2015
On the Incorrect Statistical Calculations of the Kinetica Software Package in Imbalanced Designs
S Morales-Alcelay, J M de la Torre de Alvarado, A García-Arieta
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
April 23, 2018
Defining level A IVIVC dissolution specifications based on individual in vitro dissolution profiles of a controlled release formulation
I González-García, A García-Arieta, M Merino-Sanjuan, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
March 7, 2000
Quantitative determination of dimethicone in commercial tablets and capsules by Fourier transform infrared spectroscopy and antifoaming activity test
G Torrado, A García-Arieta, F de los Ríos, et al.
Clinical Pharmacology and Therapeutics
|
July 3, 2014
Adjusted indirect treatment comparison of the bioavailability of WHO-prequalified first-line generic antituberculosis medicines
L Gwaza, J Gordon, J Welink, et al.
Die Pharmazie
|
February 15, 2018
IVIVC approach based on carbamazepine bioequivalence studies combination
I González-García, V Mangas-Sanjuan, M Merino-Sanjuán, et al.
Page
of 1